Teva Drug Would Infringe Mylan Patent, Judge Says
A West Virginia federal judge ruled Wednesday that an treatment proposed by generic drugmaker Teva Pharmaceutical USA Inc. would violate a patent covering Mylan Inc.'s respiratory illness drug Perforomist....To view the full article, register now.
Already a subscriber? Click here to view full article